十二月 2025
- Home
- ASCO Connection Groups
十二月 2025的ASCO Connection Groups市场份额分析
ASCO Connection Groups(包含公司地区分支机构)
查看更多网站流量和参与度信息- asco.org
ASCO Connection Groups收入截至 十二月 2025为 100M - 200M
ASCO Connection Groups主要域名产生的收入
3 年中ASCO Connection Groups主要域名的收入
ASCO Connection Groups主要域名的收入
ASCO Connection Groups热门域名的总访问量
了解ASCO Connection Groups市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
ASCO Connection Groups热门域名的平均访问时长
分析ASCO Connection Groups参与度指标。
过去 3 个月的平均访问时长
子公司明细
ASCO Connection Groups热门域名的平均页面浏览量
了解ASCO Connection Groups如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
ASCO Connection Groups 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻American Society Of Clinical Oncology, Inc. attended event 67th American Society of Hematology (ASH) Annual Meeting and Exposition on Jul 1st '25.This product release comes on the heels of Atropos Health announcing the integration of the American Society of Clinical Oncology(R)(ASCO(R) Guidelines into their platform and presenting rare disease AI algorithms at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition last year.
一月 12, 2026阅读更多
新闻American Society Of Clinical Oncology, Inc. attended event Gastrointestinal Cancers Symposium 2026 on Jan 6th '26.COVINGTON, Ky., Jan. 6, 2026 /PRNewswire/ - Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), today announced that the Company will participate in the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 taking place January 8-10, 2026, in San Francisco, California.
一月 7, 2026阅读更多
新闻American Society Of Clinical Oncology, Inc. attends event Integra Connect Golf Classic.Golfing to Conquer Cancer at the Integra Connect Golf Classic | Conquer Cancer, the ASCO Foundation.
十一月 3, 2025阅读更多
查看 ASCO Connection Groups 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。